Sample | Title | Value | Rank |
GSM1256964 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 1 | 14.177 | 51 |
GSM1256965 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 2 | 18.7328 | 58 |
GSM1256966 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 3 | 7.71366 | 37 |
GSM1256967 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 4 | 27.0821 | 61 |
GSM1256980 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 54 before YFV | 28.7966 | 60 |
GSM1256984 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 54 seven days after YFV | 7.79381 | 34 |
GSM1256981 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 55 before YFV | 29.0966 | 61 |
GSM1256985 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 55 seven days after YFV | 44.7912 | 66 |
GSM1256982 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 56 before YFV | 17.9149 | 52 |
GSM1256986 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 56 seven days after YFV | 23.4207 | 58 |
GSM1256983 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 57 before YFV | 29.9586 | 62 |
GSM1256987 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 57 seven days after YFV | 16.253 | 53 |